CellOrigin Biotech has a long term focus on iPSC-derived innate immune cells and its applications in new cancer immune cells. Dr. Jin Zhang, the scientific co-founder of CellOrigin used to be trained as a research fellow at the Boston Children’s Hospital and Harvard Medical School. His team worked closely with clinicians at the First Affiliated Hospital of Zhejiang University and for the first time reported the induced pluripotent stem cell or iPSC-derived CAR-macrophages (CAR-iMac), and its applications in cancer immunotherapies.
As for now, CellOrigin Biotech holds its proprietary technologies for iPSC-derived CAR-Macrophage. With this platform, they are collaborating with research groups in genome engineering and synthetic biology at Harvard and MIT to fully unleash the potential of iPSC-derived immune cells, which are highly editable, expandable and clonal. Eventually, they would like to achieve a goal of bring more effective, universal and safe immune cell products to cancer patients, especially for those with solid tumors. The investigator initiated trials has been initiated at the First Hospital of Zhejiang University. The core proprietary technology platform and the core patents including the engineered macrophages from pluripotent stem cells has been authorized and is in the process of entering the US, Australia, South Africa, etc.
Company Details
- Employees
- 4
- Address
- Hangzhou, Zhejiang, Cn
- Industry
- Biotechnology
- HQ
- Hangzhou, Zhejiang
Cellorigin Biotech Questions
Cellorigin Biotech's website is http://en.cell-origin.com/intro/5.html
Cellorigin Biotech's LinkedIn profile is https://cn.linkedin.com/company/cellorigin-biotech
Cellorigin Biotech has
4 employees.
View email and phone details for 4
employees at Cellorigin Biotech.
Cellorigin Biotech's industry is
Biotechnology
Cellorigin Biotech's top competitors are
Edigene Inc.,
Kenai Therapeutics,
Shoreline Biosciences, Inc.,
Greenstone Biosciences,
Heartseed Inc.,
Avery Therapeutics, Inc.,
Cytovia Therapeutics,
Vita Therapeutics,
Hebecell Corp,
Cynata Therapeutics.
Cellorigin Biotech's categories are Biotechnology
